govt.chinadaily.com.cn

Home> Topics > Medical Products > Drugs

NMPA, Ministry of Public Security, National Health Commission issues the Announcement on the Inclusion of Oxycodone-Containing Compound Preparations in the Management of Psychotropic Substances

NMPA issues the Announcement on Issues Pertaining to the Implementation of Drug Standards in the Consistency Evaluation of the Quality and Efficacy of Generic Drugs

Provisions for Supervision of Drug Distribution

Provisions for In-vitro Diagnostic Reagent Registration

Provisions for Drug Registration

Provisions for Drug Insert Sheets and Labels

Good Manufacturing Practice for Drugs (2010 Revision)

NMPA issues the Announcement on Cancellation of 16 Certification Items (Second Batch)

General Office of the State Council issues the Opinions on Establishing a Team of Professionalized & Specialized Drug Inspectors

Main responsibilities of the National Medical Products Administration

NMPA issues the Announcement on the Requirements for Dossiers and Samples for Verification and Inspection of Specifications for Overseas New Drugs Urgently Needed in Clinical Settings

NMPA issues the Announcement on Issues Concerning the Further Improvement of Drug-related Associated Review & Approval and Supervision

< 1 2

MOST POPULAR

Editors' Picks

LEAVE YOUR MESSAGE

*Your E-mail Address

Copyright©2024 China Daily. All rights reserved.

京ICP备13028878号-6

京公网安备 11010502032503号 京公网安备 11010502032503号